The study found that although 39 % of women reported an increase in seizure activity during their pregnancy, 33 % actually a decrease in seizures and 28 % no change. The health of the baby was born as with women who found no epilepsy. ‘These prices are more in line with what reported for pregnant women with epilepsy with other drugs, and show the effectiveness of drug monitoring,’says Dr. Ologist. ‘Our findings provide the basis for treatment guidelines to prevent increased seizure frequency ultimately improve the ultimately improve the health of mother and fetus. ‘.
It is really an advantage for mothers and babies, she adds.The study, supported by grants from the National Institutes of Health, also found the amount of lamotrigine leaving the blood during pregnancy was in white women compared to black women.###Dr. Pennell is the Chairman – elect of the National Professional Advisory Board of the Epilepsy Foundation. Her new role will be officially announced at the annual meeting of the American Epilepsy Society meeting in December..Our data highlight that physicians and patient have to of these complications which may occur without abdominal pain be vigilant, says Matteson. straight stopping smoking and reducing the use corticosteroid appears to be in order the bottom a risk out of big Eq complications importance.
About Aegis TherapeuticsAegis Therapeutics is drug delivery drug delivery markets its markets its patented and proprietary drug delivery and drug galenical formulation technologies with product-specific license. Our range of patented Intravail The drug delivery technology allows non-invasive delivery of wide variety of protein, peptide and non-peptide drugs, macromolecule only be given by only be administered by injection. Aegis ‘ Intravail absorption enhancement agents do exceptionally large capacity and unique bio, peptide therapeutics. Efficient subcutaneous injection of via the intranasal administration directions.